INFLA HARMONY™: Titrated Formula for Joints – Inflammation

The part most products in this category refer to is cartilage. Inserm, the French national medical research institute, describes it as “a tissue whose function is essentially to transmit and distribute load when joints are put under stress,” and adds that “it acts, in a sense, as a ball bearing and a shock absorber between the ends of the bones.”

Its cells, chondrocytes, are “embedded in an abundant extracellular matrix made up mainly of collagen fibres and proteoglycans.” And one detail explains a great deal about this tissue: it “is characterised by having neither nerve supply nor blood supply.”

Source (French research institute, quotes translated from French): Inserm, “Repairing cartilage,” inserm.fr. Accessed 22 August 2026.

ANSES, France’s food safety agency, repeats the European definition: “foodstuffs the purpose of which is to supplement the normal diet and which are concentrated sources of nutrients or other substances with a nutritional or physiological effect, alone or in combination” (Directive 2002/46/EC, transposed by Decree No. 2006-352 of 20 March 2006).

The point that matters for comparing two products comes right after: “Unlike medicines, the marketing of food supplements does not require market authorisation.” These products are subject to declarations, and “the manufacturer is responsible for the compliance of food supplements placed on the market with the regulations in force, both in terms of safety and consumer information.”

In other words, no one has vetted a promise on your behalf before it reaches the shelf. One more reason to look at the figures.

Source (French agency, quotes translated from French): ANSES, “Food supplements: the need for informed consumption,” 21 March 2025. Accessed 22 August 2026.

Much less than what you read. ANSES states it as a definition: “A food supplement is not a medicine, and can therefore not, by definition, claim any therapeutic effect.” It adds that “to date, a limited number of health claims are authorised.”

The scale of the task explains this scarcity. EFSA states that it has published 125 scientific opinions covering more than 900 claims, out of a list of 4,637 claims transmitted to it by the European Commission between July 2008 and March 2010.

The practical consequence when you compare: a page that promises you a result steps outside the framework. We therefore state on this page only what the framework allows, and nothing more.

Sources (French agency, quotes translated from French, plus EFSA): ANSES, “Food supplements: the need for informed consumption,” 21 March 2025; EFSA, “Health claims” topic page, efsa.europa.eu. Accessed 22 August 2026.

One nuance exists, however, and we apply it. Among the claims still pending are statements relating to joint health, usable under the transitional regime provided for in Article 28 of the Regulation. On this basis, and this basis only, this page states that turmeric and boswellia contribute to joint health. No statement referring to a disease is possible, and you will find none here.

No. This is not a note of caution, it is the very definition of the product. ANSES, France’s food safety agency, writes: “A food supplement is not a medicine, and can therefore not, by definition, claim any therapeutic effect.”

The Agency also puts the advice of a professional at the top of its five recommendations for limiting risk: “Seek advice from a health professional.” And among its recommendations to consumers, it asks people to “seek a doctor’s opinion when consuming food supplements” and to “report their consumption of food supplements to their doctor or pharmacist.”

This type of product therefore replaces nothing: neither being examined, nor what a doctor decides afterwards. If something persists and worries you, the right approach is a consultation, not a comparison of bottles.

Sources (French agency, quotes translated from French): ANSES, “Food supplements: the need for informed consumption,” 21 March 2025; ANSES, “Certain joint-targeted food supplements not recommended for at-risk populations,” 29 March 2019. Accessed 22 August 2026.

Two molecules dominate the shelf. ANSES presents them as follows: “Glucosamine and chondroitin sulfate are molecules naturally present in the connective and cartilaginous tissues of the body, and contribute, among other things, to the structure and elasticity of cartilage, tendons and skin.” It notes that “in France, numerous food supplements containing glucosamine and/or chondroitin sulfate […] are available on the market.”

Next come plant extracts, including turmeric, which is very common in this category. This formula belongs to the second family: it contains neither glucosamine nor chondroitin sulfate, and its full composition appears in the Ingredients tab on this page.

Source (French agency, quotes translated from French): ANSES, “Certain joint-targeted food supplements not recommended for at-risk populations,” 29 March 2019. Accessed 22 August 2026.

Yes, and it is a comparison criterion that almost no product page displays. After analysing reports received through its nutrivigilance scheme, ANSES advises against supplements containing glucosamine and/or chondroitin sulfate for four groups: “people with diabetes or pre-diabetes, asthma, or treated with vitamin K antagonists,” “people with a food allergy to crustaceans or insects, for glucosamine-based food supplements,” “people whose diet is controlled for sodium, potassium or calcium,” and “pregnant or breastfeeding women and children, owing to insufficient safety data for these products.”

The Agency also considers it necessary for the maximum daily doses of these two compounds to “be harmonised at European level based on safety data from robust safety studies, which are currently lacking.”

This formula contains neither of these two compounds. The people it is not recommended for are listed below and in the Precautions for Use tab.

Source (French agency, quotes translated from French): ANSES, “Certain joint-targeted food supplements not recommended for at-risk populations,” 29 March 2019. Accessed 22 August 2026.

Because the word covers very different things. ANSES separates the classic forms, “turmeric rhizome powder” and “turmeric extracts, whether or not enriched in curcumin,” from “new forms that increase the bioavailability of curcumin”: combinations with piperine or turmeric essential oil, and “more elaborate forms: phytosomal complex, micelle, colloidal nanoparticles, cyclodextrin encapsulation.”

Then comes the sentence that should guide how you read a label: “To date, the food supplement label rarely states whether the formulation is classic or new.”

This is exactly the information this page publishes. The curcumin used here is Longvida®, encapsulated in a complex of phospholipids and fatty acids, obtained through the patented “Solid Lipid Curcumin Particle” technology. So you know which family it belongs to.

Source (French agency, quote translated from French): ANSES, “Adverse effects linked to the consumption of food supplements containing turmeric,” 27 June 2022. Accessed 22 August 2026.

There is one, expressed as a figure, and that is rare in this category. ANSES writes: “For a level of curcumin consumption with no risk to health, EFSA has set the acceptable daily intake (ADI) at 180 mg of curcumin per day for a 60 kg adult.” It concludes that “the amount provided by food supplements should remain below 153 mg per day for a 60 kg adult,” so that total dietary intake does not exceed this ADI.

An important warning comes with this figure: “this value is valid only for food supplement formulations containing curcumin in classic form.”

The figures for this formula, for information and without drawing any conclusion from them: the daily dose of four capsules provides 400 mg of Longvida® curcumin, that is 92 mg of curcuminoids, and the extraction form is clearly stated on this page.

Source (French agency, quotes translated from French, figures originally set by EFSA): ANSES, “Adverse effects linked to the consumption of food supplements containing turmeric,” 27 June 2022. Accessed 22 August 2026.

No, and it would be dishonest to suggest otherwise on the page of a product that has specifically chosen an encapsulated form. The starting point is a fact: “Curcumin has very low bioavailability, meaning it passes into the bloodstream with difficulty and is eliminated very quickly by the body,” ANSES summarises.

But the Agency goes further, and this is the part product pages rarely quote: formulations designed to improve this bioavailability “may carry a risk of adverse health effects by increasing the bioavailability of curcumin in the body,” “even where they do not appear to exceed the ADI.” It therefore recommends “that companies placing these products on the market provide details of their products’ bioavailability data.”

Better absorption is therefore not a selling point, it is a characteristic, and one that should be disclosed. We disclose ours. And if you are affected by any of the situations listed below, a doctor’s opinion comes before any comparison.

Source (French agency, quotes translated from French): ANSES, “Adverse effects linked to the consumption of food supplements containing turmeric,” 27 June 2022. Accessed 22 August 2026.

First, by knowing what the label is not required to tell you. ANSES is explicit: “Unlike medicines, food supplements do not carry a mandatory information leaflet on which safety information could be brought to consumers’ attention. Only a few brief pieces of information, such as the identity of the ingredients, must appear on the labelling.”

Four columns are then enough to tell two products apart. The amount, relative to the full daily dose rather than to a single capsule. The standardisation, meaning the content of active molecules in the extract. The extraction form. And the list of people the product is not recommended for.

Among its points of vigilance on plants used in food supplements, EFSA also notes the need to ensure that concentrations of active substances remain within safe limits.

Sources (French agency, quote translated from French, plus EFSA): ANSES, “Plant-based food supplements: towards better consumer information,” 8 June 2023; EFSA, “Botanicals” topic page, efsa.europa.eu. Accessed 22 August 2026.

No, and ANSES, France’s food safety agency, is careful to say so: “the mere mention of the presence of plants in food supplements can sometimes be falsely reassuring for the consumer, whereas certain plants may present a risk under certain conditions of use, depending on the type of plant extract or the sensitivity of particular populations, such as pregnant women or children.”

In the same opinion, the Agency notes that these products “are far from harmless” and “can cause adverse effects that are sometimes serious, such as severe allergies or potentially fatal liver damage.” It has published, for health professionals, a table covering 118 medicinal plants used in food supplements and their precautions for use.

Source (French agency, quotes translated from French): ANSES, “Plant-based food supplements: towards better consumer information,” 8 June 2023. Accessed 22 August 2026.

ANSES recommends the opposite. In its advice to consumers, it asks people to “avoid getting the same ingredient from different sources (food supplements, medicines, etc.),” to “avoid consuming several food supplements at the same time,” and to “favour food supplements with simple formulations.”

Worth stating ourselves: with five actives, this formula is not what ANSES would call a simple formulation. It is a deliberate choice, and it is also one more reason not to combine it with other products without speaking to a health professional first.

Sources (French agency, quotes translated from French): ANSES, “Certain joint-targeted food supplements not recommended for at-risk populations,” 29 March 2019; ANSES, “Food supplements: the need for informed consumption,” 21 March 2025. Accessed 22 August 2026.

There is a scheme for this. ANSES “set up a nutrivigilance scheme in 2009 to monitor adverse effects linked to the consumption of food supplements and other food products.” This scheme “makes it possible to collect and identify adverse effects reported by health professionals, in particular doctors and pharmacists, manufacturers or distributors, as well as any member of the public.”

The steps to follow are therefore simple: stop taking the product, speak to a doctor or pharmacist, and report the effect to ANSES’s nutrivigilance scheme.

Sources (French agency, quotes translated from French): ANSES, “Food supplements: the need for informed consumption,” 21 March 2025; ANSES, “Certain joint-targeted food supplements not recommended for at-risk populations,” 29 March 2019. Accessed 22 August 2026.

ANSES suggests starting with a question rather than a product: “Before consuming a food supplement, the first question to ask is: do I really need it?” And it sets out the starting point: “Generally speaking, in the absence of any illness, nutritional needs can be met through a varied, balanced diet as part of a physically active daily life. Consuming food supplements is then not necessary.”

On physical activity, Assurance Maladie, France’s national health insurance body, gives figures: “Physical activity needs to be regular to have a positive effect on health. This is why it is recommended to exercise at least five days out of seven, and ideally every day.” It also sets a target for sedentary time: “gradually reducing total sedentary time to less than 7 hours a day between waking and going to bed,” and advises breaking up this time “with 5- to 10-minute breaks every 2 hours.” For adults, “10,000 steps a day (equivalent to 1.5 to 2 hours of walking) is recommended, between 7,000 and 10,000 for people over 65.”

A supplement is compared after that, not instead of it.

Sources (French agencies, quotes translated from French): ANSES, “Food supplements: the need for informed consumption,” 21 March 2025; Assurance Maladie, “Recommended daily physical activity and tackling sedentary behaviour,” ameli.fr. Accessed 22 August 2026.

No reference duration is set for this type of product, and we will not invent one. What is known is what is practised and what is advised. ANSES notes that “the average annual duration of taking a food supplement is 4.5 months among adults,” with wide variation from one person to another.

Among its five pieces of advice for limiting risk is this one, which applies to the whole category: “Avoid prolonged, repeated or multiple use.” A health professional remains the right person to advise on your particular case.

Source (French agency, quote translated from French): ANSES, “Food supplements: the need for informed consumption,” 21 March 2025. Accessed 22 August 2026.

It is not recommended in cases of biliary obstruction or biliary function disorders, for pregnant or breastfeeding women, for people with diabetes, or when taking anticoagulants, anticancer medicines or immunosuppressants. Do not exceed the recommended daily dose. Keep out of reach of young children.

These exclusions are not arbitrary. ANSES “advises against the consumption of turmeric-based food supplements by people suffering from disorders of the biliary tract,” as turmeric stimulates bile secretion. It also flags “a risk linked to interactions between curcumin and certain medicines such as anticoagulants, anticancer medicines and immunosuppressants,” whose “efficacy or safety could be affected,” and advises against these products for people undergoing such treatment “without medical advice.”

Source (French agency, quotes translated from French): ANSES, “Adverse effects linked to the consumption of food supplements containing turmeric,” 27 June 2022. Accessed 22 August 2026.

None on the product itself: it is the same 120-capsule bottle in all four cases, with the same composition and the same dose of four capsules a day. The only difference is the pack size and the price per bottle.

Single purchase at €39.90 instead of €49.90. Pack of 2 at €74.90 instead of €89.90. Pack of 3 at €99.90 instead of €124.90. Monthly subscription at €29.90 instead of €49.90, with free delivery on renewals and cancellation possible at any time.

One bottle covers thirty days. That is the only figure you need to work out what suits you.

There is only one product behind the pages in this range. The composition does not vary from page to page, nor does the bottle, nor does the daily dose. No version is more concentrated, none is reserved for a particular profile. What differs is only the angle from which the composition is explained, and the list of questions each page takes the time to answer.

This page is written for the person who compares before buying, without a fixed idea of what they are looking for, and who first wants to understand what this type of product contains and on what criteria to judge it. The other pages start from a different life context, with the same public sources and the same composition: joint supplement for over-50s, if your sporting activity is intense, if your day is spent in front of a screen, if your lower back keeps coming up in your searches, if your situation has gone on for a long time.

If you are still unsure, two habits are worth more than any comparison: reading the Ingredients tab on this page, which contains every amount and standardisation, and asking a health professional for advice, especially if you are already on a treatment.

On the topic of joints, European regulation authorises one statement under the pending claims: boswellia contributes to the health of joints and bones. This formula provides 307 mg per daily dose, as a concentrated extract standardised to 65% boswellic acids, providing 200 mg of boswellic acids.

Beyond this sentence, nothing more can be stated, by us or by anyone else.

The same framework applies: turmeric contributes to joint health. This formula provides 400 mg of Longvida® curcumin, including 92 mg of curcuminoids, extracted using the patented “Solid Lipid Curcumin Particle” technology.

As ordinary curcumin is very poorly absorbed, it was the form that guided this choice, not the raw quantity. Here again, nothing else can be stated.